Zachary Carpenter
Corporate Officer/Principal at Roivant Sciences, Inc.
Network origin in Zachary Carpenter first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
Roivant Sciences, Inc.
 Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY.
34
| Subsidiary | Pharmaceuticals: Major | 34 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Zachary Carpenter via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| RITE AID CORPORATION | Drugstore Chains | Director/Board Member Chief Administrative Officer | |
| CAREDX, INC | Medical Specialties | Director/Board Member Director of Finance/CFO | |
QVT Financial LP
 QVT Financial LP Investment ManagersFinance QVT Financial LP is an independent, SEC-registered investment advisor and hedge fund manager headquartered in New York City. The firm was founded in 2003 by Daniel Gold. QVT Financial provides administrative and/or investment management services to private funds including US limited partnerships, non-US limited partnerships and non-US Corporation. | Investment Managers | Portfolio Manager-Equities Analyst-Equity | |
| ARBUTUS BIOPHARMA CORPORATION | Pharmaceuticals: Major | Director/Board Member Director/Board Member Chairman Chairman Director/Board Member | |
| AXSOME THERAPEUTICS, INC. | Biotechnology | Director/Board Member Director/Board Member | |
Arbutus Biopharma, Inc.
 Arbutus Biopharma, Inc. BiotechnologyHealth Technology Arbutus Biopharma, Inc. engages in the research and development of pharmaceutical products for Hepatitis B. Its operation includes covalently closed circular DNA, Capsid Assembly, Cyclophilins, and Surface Antigen. The company was founded by Patrick T. Higgins, Michael J. Sofia, Michael J. McElhaugh, and Bryce A. Roberts in May 2012 and is headquartered in Doylestown, PA. | Biotechnology | Director/Board Member Director/Board Member | |
| ROIVANT SCIENCES LTD. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Chief Executive Officer Chairman Comptroller/Controller/Auditor Chief Executive Officer President Director of Finance/CFO | |
| GSK PLC | Pharmaceuticals: Major | Corporate Officer/Principal | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Graduate Degree Undergraduate Degree | |
| XENON PHARMACEUTICALS INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| The University of Chicago | College/University | Director/Board Member Doctorate Degree | |
| Lehigh University | College/University | Undergraduate Degree Masters Business Admin | |
Lilly Research Laboratories
 Lilly Research Laboratories Miscellaneous Commercial ServicesCommercial Services Part of Eli Lilly & Co., Lilly Research Laboratories is a company that engages in research and develops medicines. The company is based in Indianapolis, IN. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Point32health Services, Inc.
 Point32health Services, Inc. Life/Health InsuranceFinance Tufts Associated Health Plans, Inc. provides healthcare plans. It offers health care coverage options to individuals and employer groups. The firm also offers choice tiered network option plan and Steward Community Choice, a community-based plan, developed in conjunction with Steward Health Care System. The company was founded by Morton A. Madoff in 1979 and is headquartered in Watertown, MA. | Life/Health Insurance | Director/Board Member | |
| University of Lucknow | College/University | Doctorate Degree | |
| KARA THER | Pharmaceuticals: Major | Director/Board Member | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Undergraduate Degree | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin | |
| Harvard Law School | College/University | Graduate Degree Graduate Degree | |
| Yale Law School | College/University | Graduate Degree Graduate Degree | |
| Harvard College | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| University of Michigan Medical School | College/University | Corporate Officer/Principal | |
| UNC School of Medicine | College/University | Doctorate Degree Doctorate Degree | |
Roivant Sciences GmbH
 Roivant Sciences GmbH Pharmaceuticals: MajorHealth Technology Roivant Sciences GmbH engages in the development and marketing of biopharmaceutical products. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Chief Executive Officer Chief Operating Officer | |
| TOBIRA THERAPEUTICS INC | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| SIO GENE THERAPIES INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member Director/Board Member Director/Board Member Director of Finance/CFO Director/Board Member Chairman Chief Executive Officer Director/Board Member Director/Board Member | |
| PURETECH HEALTH PLC | Biotechnology | Chief Tech/Sci/R&D Officer | |
| EARGO, INC. | Medical Specialties | Director/Board Member | |
Axovant Sciences, Inc.
 Axovant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Part of Sio Gene Therapies, Inc., Axovant Sciences, Inc. is a company that manufactures and distributes pharmaceutical products. The company is based in New York, NY. | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO Chairman Chief Executive Officer General Counsel | |
| MYOVANT SCIENCES LTD. | Biotechnology | Director/Board Member Chairman Director/Board Member Director/Board Member Chairman Director/Board Member Director/Board Member | |
Dermavant Sciences, Inc.
 Dermavant Sciences, Inc. BiotechnologyHealth Technology Part of Roivant Sciences Ltd., Dermavant Sciences, Inc. develops biological products. The company is based in Raleigh, NC. Todd Zavodnick has been the CEO of the company since 2018. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member Chairman | |
Xoc Pharmaceuticals, Inc.
 Xoc Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Xoc Pharmaceuticals, Inc. operates as Biopharmaceutical Company. It focuses on the development of innovative therapeutics. The company was founded by Scott W. Borland, Miguel Guzman and Lisa Borland and is headquartered in Los Gatos, CA. | Miscellaneous Commercial Services | Chairman Director/Board Member | |
Urovant Sciences, Inc.
 Urovant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Part of Sumitomo Chemical Co., Ltd., Urovant Sciences, Inc. is a pharmaceutical company that prioritizes diversity, equity, and inclusion in rewriting how care is provided in urology. The company is based in Irvine, CA and offers programs to improve patient care, with a current focus on overactive bladder. Urovant Sciences is expanding opportunities to help patients in and beyond, with links to marketed product sites for patients and healthcare professionals, plus patent information. Recently, Sumitovant Biopharma Ltd. announced that its parent company Sumitomo Pharma Co., Ltd. will combine its wholly owned subsidiaries to form Sumitomo Pharma America, Inc., which will include Urovant Sciences and other subsidiaries. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member Chief Tech/Sci/R&D Officer | |
| UROVANT SCIENCES LTD. | Pharmaceuticals: Major | Chairman Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
| Alyvant, Inc. | President General Counsel | ||
Altavant Sciences, Inc.
 Altavant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Altavant Sciences, Inc. is a clinical stage biopharmaceutical company, which provides therapies that treat respiratory diseases with an initial therapeutic focus in pulmonary arterial hypertension (PAH). The company is headquartered in Cary, NC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Dermavant Sciences Ltd.
 Dermavant Sciences Ltd. Pharmaceuticals: MajorHealth Technology Dermavant Sciences Ltd. is a clinical-stage biopharmaceutical company which focuses on developing and commercializing therapeutics in medical dermatology. The company is developing a pipeline of therapies in medical dermatology and is currently advancing development programs for five product candidates which targets specific unmet needs in two of the immuno-dermatology markets, psoriasis and atopic dermatitis, as well as other large markets, including vitiligo, primary focal hyperhidrosis and acne. The company was founded on September 28, 2015 and is headquartered in London, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member Chairman | |
Aruvant Sciences, Inc.
 Aruvant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Aruvant Sciences, Inc. operates as a clinical-stage biopharmaceutical company. The firm develops and commercializes gene therapies for hematological diseases utilizing reduced-intensity conditioning. It's lead candidate ARU-1801, is a modified fetal hemoglobin gene therapy for sickle cell disease and related hemoglobinopathies. The company is headquartered in New York, NY. | Pharmaceuticals: Major | Chairman Director/Board Member | |
Immunovant Sciences Ltd.
 Immunovant Sciences Ltd. BiotechnologyHealth Technology Part of Roivant Sciences Ltd., Immunovant Sciences Ltd. develops restorative therapies for autoimmune diseases. The company is based in Hamilton, Bermuda. Immunovant Sciences was acquired by Health Sciences Acquisitions Corp. from Roivant Sciences Ltd. on December 19, 2019 for $863.06 million. | Biotechnology | Director/Board Member Director/Board Member Chairman | |
| IMMUNOVANT, INC. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member Chairman Director/Board Member | |
Sumitovant Biopharma, Inc.
 Sumitovant Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Sumitovant Biopharma, Inc. provides biotechnology services. It offers oncology, gene therapy, rare, pulmonary, urological disease, digital innovation and novel platforms. The company is headquartered in New York, NY. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member Director/Board Member | |
Kriya Therapeutics, Inc.
 Kriya Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Kriya Therapeutics, Inc. designs and develops transformative new treatments for prevalent and severe chronic diseases. The company was founded by Shankar Ramaswamy and Roger Jeffs and is headquartered in Redwood City, CA. | Miscellaneous Commercial Services | Founder Director/Board Member Director/Board Member | |
| Roivant Social Ventures, Inc. | Director/Board Member Director/Board Member Director/Board Member |
Statistics
International
| United States | 42 |
| United Kingdom | 5 |
| Bermuda | 3 |
| Canada | 2 |
| India | 2 |
Sectoral
| Health Technology | 30 |
| Consumer Services | 12 |
| Finance | 5 |
| Commercial Services | 4 |
| Retail Trade | 2 |
Operational
| Director/Board Member | 251 |
| Independent Dir/Board Member | 82 |
| Corporate Officer/Principal | 68 |
| Director of Finance/CFO | 44 |
| Chairman | 44 |
Most connected contacts
| Insiders | |
|---|---|
| Pierre Legault | 45 |
| Myrtle Potter | 41 |
| George Bickerstaff | 37 |
| Frank Torti | 35 |
| Clarence Machado | 30 |
| Kenneth Ludlum | 23 |
| Berndt A. E. Modig | 23 |
| Alan Roemer | 21 |
| Atul Pande | 20 |
| Roger Jeffs | 18 |
| Kathleen Sebelius | 18 |
| Andrew Fromkin | 16 |
| Keith Manchester | 15 |
| Vivek Ramaswamy | 14 |
| David S. Moore | 13 |
- Stock Market
- Insiders
- Zachary Carpenter
- Company connections
